Corporate
  • bioMérieux

    Created in 1963
  • Social networks

    1,684 310,295
  • Sectors

  • Location

    100 All. Louis Raymond, 69280 Marcy-l'Étoile, France

    Marcy-l'Étoile

    France

  • Engaged entities

    247
    181 48
  • Added in Motherbase

    18 Sep 2019, 4:49 p.m.
Description
  • Value proposition

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP


    in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis

  • Original language

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP

Entity interactions BETA
Entity TypeTweets Articles
1CABASPOUR1ETUDIANT 1CABASPOUR1ETUDIANT
IT Services, Non-profit Organizations
Other

22 Mar 2024


42 Lyon Auvergne-Rhône-Alpes 42 Lyon Auvergne-Rhône-Alpes
Higher Education, edtech
Other

20 Oct 2023


60 000 rebonds 60 000 rebonds
edtech, Civic and Social Organizations
Other

3 Jan 2024


Abingdon Health plc Abingdon Health plc
biotech, manufacturing, deeptech, healthtech, Medical Equipment Manufacturing
Other

18 Mar 2024


ABL ABL
biotech, deeptech, Pharmaceutical Manufacturing
Other

5 Jul 2023


Acteurs de La French Care Acteurs de La French Care
healthtech, Hospitals and Health Care
Other

31 May 2023


AddWorking AddWorking
fintech, Software Development
Other

2 Oct 2022


ADERLY / Invest in Lyon Agency ADERLY / Invest in Lyon Agency
International Trade and Development
Other

29 Oct 2023


ADIE ADIE
fintech, Civic and Social Organizations
Other

9 Jan 2024


ADIRA ADIRA
Information Services, IT Services
Other

19 Oct 2023


Radars
Loading...